As of the latest SEC filings, ASTREZENECA PHARMA (ASTR) is held by 6 institutional funds. The largest fund shareholder is Avantis Emerging Markets Equity ETF (AVEM), holding an estimated $263,965.87 in market value, representing a significant portion of its portfolio.
Funds holding ASTREZENECA PHARMA (ASTR)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- ASTR
- CIK:
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
AVEM
Avantis Emerging Markets Equity ETF
|
ETF | American Century | 0.00% | $263,965.87 | 2,704 | Feb 28, 2026 | Apr 29, 2026 |
|
DGS
WisdomTree Emerging Markets SmallCap Dividend Fund
|
ETF | WisdomTree | 0.00% | $65,825.45 | 804 | Mar 31, 2026 | Jun 1, 2026 |
|
AVEE
Avantis Emerging Markets Small Cap Equity ETF
|
ETF | American Century | 0.03% | $28,407.57 | 291 | Feb 28, 2026 | Apr 29, 2026 |
|
AVXC
Avantis Emerging Markets ex-China Equity ETF
|
ETF | American Century | 0.01% | $25,381.33 | 260 | Feb 28, 2026 | Apr 29, 2026 |
|
AVSE
Avantis Responsible Emerging Markets Equity ETF
|
ETF | American Century | 0.01% | $20,402.69 | 209 | Feb 28, 2026 | Apr 29, 2026 |
|
IND
Xtrackers Nifty 500 India ETF
|
ETF | Independent / Boutique | 0.03% | $1,264.47 | 13 | Feb 28, 2026 | Apr 29, 2026 |
Advertisement (320x50)